DCN MONTHLY SERIES: Management of Pancreatic Cancer 2022 (October)

The purpose of this offering is to provide updates surrounding pancreatic cancer. This will be accomplished with the following objectives: discuss the standard of care treatments for pancreatic cancer, understand when to consider adjuvant therapy and the benefit to survival outcome after resection, identify adverse effects from various recommended treatments, and review how to maximize disease control with the metastatic disease while maintaining the quality of life.

Target Audience

  • MD
  • RN
  • Pharmacy
  • Pharmacy Tech
  • NP
  • PA

Learning Objectives

  • Discuss standard of care treatments for pancreatic cancer
  • Understand when to consider adjuvant therapy and the benefit to survival outcome after resection
  • Identify adverse effects from various recommended treatments
  • Review how to maximize disease control with metastatic disease while maintaining quality of life
Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
12/27/2022
Registration Expires: 
12/27/2024
Rating: 
0

Dr. S. David Hsu, MD, Ph.D

ANCC

ACPE

AMA

JA-AH

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.